Leggett Thomas
Chief Financial Officer
Leggett Thomas has filed 2 SEC Form 4 filings (6 transaction rows) across 1 company, with disclosures dating back to 2026. 2 of those filings fall inside the rolling window. Most recent filing: Mar 19, 2026.
On the most recent filing, Leggett Thomas is listed as Chief Financial Officer at Stoke Therapeutics, Inc. Inside the rolling window, Leggett Thomas reported no open-market purchases and 2 open-market sales totaling $147K in STOK. The largest disclosed transaction in the window is a sale of 2,382 STOK shares on Mar 18, 2026, worth $75K.
Companies traded
Other insiders at STOK
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$147K
reported sales (SEC code S)
Companies
1
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has Leggett Thomas made?
Leggett Thomas has filed 2 SEC Form 4 filings (6 transaction rows) across 1 company since 2026.
Which companies does Leggett Thomas trade?
Leggett Thomas has filed SEC Form 4 disclosures for 1 company, including STOK.
When was Leggett Thomas's most recent SEC Form 4 filing?
Leggett Thomas's most recent SEC Form 4 filing on Tracefour is dated Mar 19, 2026.
What is Leggett Thomas's job title?
On the most recent SEC Form 4 filings tracked by Tracefour, Leggett Thomas is listed as Chief Financial Officer.
What is Leggett Thomas's total buy and sell value in the current window?
Inside the rolling retention window, Leggett Thomas bought $0 and sold $147K based on SEC Form 4 filings.
What was Leggett Thomas's largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 2,382 STOK shares on 2026-03-18, worth $75K, per SEC Form 4 filings.